Table 1 The factors were selected as indicators of cardiac function in this study.

From: Radiological assessment of effectiveness of soluble RAGE in attenuating Angiotensin II-induced LVH mouse model using in vivo 9.4T MRI

AngII/sRAGE

EDbv

ESbv

EDmv

EDmw

LVWT

EF

(mm3)

(mm3)

(mm3)

(mg)

(μm)

(%)

Pre

−/−

44.0 ± 3.9

11.9 ± 1.7

77.1 ± 8.6

81.0 ± 9.0

656.4 ± 49.9

73.0 ± 2.6

+/−

45.7 ± 4.1

13.4 ± 3.4

73.2 ± 3.8

76.9 ± 4.0

660.0 ± 35.0

71.5 ± 6.4

−/+

50.7 ± 4.2

17.5 ± 4.6

76.8 ± 5.2

80.6 ± 5.5

632.2 ± 45.5

65.6 ± 7.8

+/+

48.6 ± 4.4

16.5 ± 4.5

78.1 ± 7.4

82.0 ± 7.8

642.2 ± 27.4

67.4 ± 6.3

Post

−/−

46.6 ± 5.4

11.5 ± 2.0

88.6 ± 6.6

93.0 ± 7.0

818.4 ± 60.5

75.4 ± 2.4

+/−

69.9 ± 19.5

26.3 ± 18.2

112.3 ± 17.7

118.0 ± 18.6

813.5 ± 66.2

68.3 ± 2.4

−/+

51.0 ± 2.7

13.7 ± 3.9

86.8 ± 7.1

91.1 ± 7.5

769.7 ± 74.3

73.2 ± 7.2

+/+

66.4 ± 9.5

23.4 ± 5.2

100.8 ± 10.5

105.8 ± 11.0

796.8 ± 53.0

65.4 ± 3.5